Dmytro Guzenko

Dmytro Guzenko

Auto-generated profile, based on publicly available information

Dmytro Guzenko

Pledge Therapeutics, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Open access
PDF file
DGDmytro Guzenko
Dmytro Guzenko
ALAleix Lafita
Aleix Lafita
BMBohdan Monastyrskyy
Bohdan Monastyrskyy
AKAndriy Kryshtafovych
Andriy Kryshtafovych
Jose A DuarteJose A Duarte
Jose A Duarte
We present the assembly category assessment in the 13th edition of the CASP community‐wide experiment. For the second time, protein assemblies constitute an independent assessment category. Compared to the last edition we see a clear uptake in participation, more oligomeric targets released, and consistent, albeit modest, improvement of the predictions quality. Looking at the tertiary structure predictions, we observe that ignoring the oligomeric state of the targets hinders modeling success. We also note that some contact prediction groups successfully predicted homomeric interfacial contacts, though it appears that these predictions were not used for assembly modeling. Homology modeling with sizeable human intervention appears to form the basis of the assembly prediction techniques in this round of CASP. Future developments should see more integrated approaches where subunits are modeled in the context of the assemblies they form.

7 October 2019 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
GHGreg L. Hura
Greg L. Hura
CHCurtis D. Hodge
Curtis D. Hodge
DRDaniel Rosenberg
Daniel Rosenberg
DGDmytro Guzenko
Dmytro Guzenko
Jose A DuarteJose A Duarte
Jose A Duarte
STSusan E. Tsutakawa
Susan E. Tsutakawa

1 January 2020 in Journal of Structural Biology
Verified
Journal Article
Closed access
ALAnastasia V. Lilina
Anastasia V. Lilina
ACAnastasia A. Chernyatina
Anastasia A. Chernyatina
DGDmytro Guzenko
Dmytro Guzenko
SSSergei Strelkov
Sergei Strelkov

21 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GMGary Garcia Molina
Gary Garcia Molina
DGDmytro Guzenko
Dmytro Guzenko
SDSusan DeFranco
Susan DeFranco
MAMark S. Aloia
Mark S. Aloia
RMRajasi Mills
Rajasi Mills
ECEve Van Cauter
Eve Van Cauter
Inadequate information exists regarding physiological changes post-COVID-19 infection. We used smart beds to record biometric data following COVID-19 infection in nonhospitalized patients. Recordings of daily biometric signals over 14 weeks in 59 COVID-positive participants’ homes in 2020 were compared with the same participants’ data from 2019. Participants completed a survey of demographic information, health conditions, COVID exposure and testing, and symptom prevalence/subjective severity. Mean age was 47.5 years (standard deviation [SD] 9.5), mean body mass index was 30.1 kg/m2 (SD 7.1), and 46% were men. During acute infection, 64% exhibited 5–6 h increased sleep duration, 51% had increased movement, and 64% had increased breathing rate (BR). Nearly 34% had paradoxical bradycardia (decreased heart rate by ~ 10 BPM concomitant with elevated BR and/or fever), with more-severe symptoms. Smart beds can detect physiological changes during COVID-19. A subtype of acute response (paradoxical bradycardia) may predict delay recovery from COVID-19.

17 September 2025 in JMIR AI
Verified
Journal Article
Open access
GMGary Garcia Molina
Gary Garcia Molina
DGDmytro Guzenko
Dmytro Guzenko
SDSusan DeFranco
Susan DeFranco
MAMark Aloia
Mark Aloia
RMRajasi Mills
Rajasi Mills
VSVirend K Somers
Virend K Somers
Background: Pathophysiological responses to viral infections such as COVID-19 significantly affect sleep duration, sleep quality, and concomitant cardiorespiratory function. The widespread adoption of consumer smart bed technology presents a unique opportunity for unobtrusive, real-world, longitudinal monitoring of sleep and physiological signals, which may be valuable for infectious illness surveillance and early detection. During the COVID-19 pandemic, scalable and noninvasive methods for identifying subtle early symptoms in naturalistic settings became increasingly important. Existing digital health studies have largely relied on wearables or patient self-reports, with limited adherence and recall bias. In contrast, smart bed–derived signals enable high-frequency objective data capture with minimal user burden. Objective: The aim of this study was to leverage objective, longitudinal biometric data captured using ballistocardiography signals from a consumer smart bed platform, along with predictive modeling, to detect and monitor COVID-19 symptoms at an individual level. Methods: A retrospective cohort of 1725 US adults with sufficient longitudinal data and completed surveys reporting COVID-19 test outcomes was identified from users of a smart bed system. Smart bed ballistocardiography-derived metrics included nightly pulse rate, respiratory rate, total sleep time, sleep stages, and movement patterns. Participants served as their own controls, comparing reference (baseline) and symptomatic periods. A two-stage analytical pipeline was used: (1) a gradient-boosted decision-tree “symptom detection model” independently classified each sleep session as symptomatic or not, and (2) an “illness-symptom progression model” using a Gaussian Mixture Hidden Markov Model estimated the probability of symptomatic states across contiguous sleep sessions by leveraging the temporal relationship in the data. Statistical analyses evaluated within-subject changes, and the model’s ability to discriminate illness windows was quantified using receiver operating characteristic metrics. Results: Out of 122 participants who tested positive for COVID-19, symptoms were detected by the model in 104 cases. Across the cohort, the model captured significant deviations in sleep and cardiorespiratory metrics during symptomatic periods compared to baseline, with an area under the receiver operating characteristic curve of 0.80, indicating high discriminatory performance. Limitations included reliance on self-reported symptoms and test status, as well as the demographic makeup of the smart bed user base. Conclusions: Smart beds represent a valuable resource for passively collecting objective, longitudinal sleep and physiological data. The findings support the feasibility of using these data and machine learning models for real-time detection and tracking of COVID-19 and related illnesses. Future directions include model refinement, integration with other health signals, and applications for population-scale surveillance of emerging infectious diseases.